MDG1:FRA
MediGene AG
0,017 €
arrow_upward
+3,61%(+0,00060) 1D
30 qer, 10:00:00 m.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
24/7 Wall St.
·
22 minuta më parë
These 3 International Dividend ETFs Outyield SCHD and Are Beating the S&P 500 Over the Past Year
The Globe and Mail
·
49 minuta më parë
Kaplan Fox Urges AST SpaceMobile, Inc. (NASDAQ: ASTS) Investors to Contact the Firm Before the Deadline on November 13, 2026
Barron's
·
5 orë më parë
The AI Trade Led the Bull Market—but Don’t Bail on the Big Winners Just Yet
Investor's Business Daily
·
1 orë më parë
Dow Jones Futures: Stock Market Holds Up As Meta, AMD Lead Buys; ASML, CPI Inflation Due
Profili
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia